Bill Detail
S. 4875
Congress: 119
Title
A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Michael Bennet [D-CO]
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Status as of Jun 29, 5:58 AM · synced 14h ago
Introduced
2026-06-23
Data source mode: cache
Bill Engagement
A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infe…
Sponsor
Sen. Michael Bennet [D-CO]D
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Cosponsors
2D · 2R
Bipartisan
LDA engagement
2 orgs · 2 filings
Top: Chamber of Commerce of the U.s.a.
Introduced
2026-06-23
Lobbyists on the case
2 orgs · 40 lobbyists · 2 filings mention S. 4875 (A bill to amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.) in LDA disclosures.
Top orgs filing
- Chamber of Commerce of the U.s.a.1 filing · 33 lobs
- National Association of Broadcasters1 filing · 7 lobs
Lobbyists on this bill
- Caroline Billman2025 Q1
- Neil Bradley2025 Q1
- Michael Chirico2025 Q1
- Suzanne Clark2025 Q1
- Kevin Courtois2025 Q1
- Christopher Crenshaw2025 Q1
- Nicholas Crocker2025 Q1
- Rodney Davis2025 Q1
+ 32 more